The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index; 31 of the 127 sources its claims cite were checked for support.
Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
Open accessAbstract
Attention-deficit/hyperactivity disorder (ADHD) in the adult population is frequently associated with comorbid psychiatric diseases that complicate its recognition, diagnosis and management.The prevalence of ADHD in the general adult population is 2.5% and it is associated with substantial personal and individual burden. The most frequent comorbid psychopathologies include mood and anxiety disorders, substance use disorders, and personality disorders. There are strong familial links and neurobiological similarities between ADHD and the various associated psychiatric comorbidities. The overlapping symptoms between ADHD and comorbid psychopathologies represent challenges for diagnosis and treatment. Guidelines recommend that when ADHD coexists with other psychopathologies in adults, the most impairing condition should generally be treated first.Early recognition and treatment of ADHD and its comorbidities has the potential to change the trajectory of psychiatric morbidity later in life. The use of validated assessment scales and high-yield clinical questions can help identify adults with ADHD who could potentially benefit from evidence-based management strategies.
Overview
CoChat Summary
TL;DR
This narrative review argues that adult ADHD is prevalent, frequently comorbid with mood, anxiety, substance use, and personality disorders, and often underrecognized and undertreated. It recommends a dimensional diagnostic approach, screening for comorbidities, and treating the most impairing condition first, with early ADHD treatment potentially altering later psychiatric morbidity.
Key findings
- Adult ADHD general population prevalence is estimated at 2.5% (95% CI 2.1–3.1); as many as 80% of adults with ADHD have at least one coexisting psychiatric disorder, and only 11% of adults with ADHD in a US National Comorbidity Survey Replication sample (n = 3199) were receiving treatment.
- Comorbidity rates are substantial: depression in individuals with ADHD ranges from 18.6% to 53.3%; comorbid ADHD in depression ranges from 9% to 16% (mean 7.8%); anxiety disorder risk approaches 50%; substance abuse/dependence is approximately twice as common; personality disorders are present in more than 50% of adults with ADHD, with 25% having two or more.
- Burden includes divorce in 28% vs 15% of controls (P ≤ 0.001), full-time employment in 34% vs 59% (P < 0.001), estimated annual US cost of $143–$266 billion, and in Denmark more than double the risk of death and lower life expectancy.
- Treatment guidance favors treating the most severe or destabilizing illness first; stimulants are first-line for ADHD, and early stimulant treatment has been associated with lower later risk of depression, anxiety, and SUD, with reviews reporting approximately 50% decreased risk of future SUDs and one review suggesting methylphenidate in children may reduce substance use/abuse by up to 85%.
Methods
- Narrative review based on PubMed searches for English articles published 1996–2016, using “adult ADHD” combined with terms including anxiety, addiction, bipolar, depression, substance use, neurobiology, prevalence, and treatment.
- Clinical trials, guidelines, meta-analyses, and systematic reviews were selected; 113 unique articles were identified, 22 were excluded (8 at title, 7 at abstract, 7 after full text), leaving 91 included, and manual searches brought the total to 150 articles.
- The paper synthesizes evidence and clinical guidance rather than conducting a formal meta-analysis.
Limitations
- The paper states that the evidence base continues to evolve, there is a lack of quality evidence to guide management of complex presentations, prospective studies of psychosocial strategies in comorbid ADHD populations are scarce, and literature on comorbid ADHD and personality disorders is sparse.
- Evident from the text: this is a narrative review with non-systematic selection and manual additions, limited to English-language articles from 1996–2016.
- The review was funded by Janssen, Purdue, and Shire, and the authors report extensive grant support, advisory board participation, and/or lecture honoraria from multiple pharmaceutical companies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Overlapping and distinctive features of ADHD and common psychiatric comorbidities (compiled from: Searight et al., 2000 [149]; Culpepper and Mattingly, 2008 [150]; Klassen et al., 2010 [17]; Bond et al., 2012 [16]; Mancini et al., 1999 [85]; CADDRA, 2011 [107]; Mao and Findling, 2014) [84]](https://figures.cochat.ai/paper-figures/8fd7f532086c47b0a4005e7e556ab73e/adult-adhd-and-comorbid-disorders-clinical-implications-of-a-dimensional-figure-1.jpg)
Verification
Claims the paper makes
22 Valid · 8 Not valid · 62 Not checked · 13 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Recent evidence supports the view that children with ADHD do not “outgrow” the disorder when they reach adulthood”
§ Adult ADHD and comorbid disorders: clinical implications of a dimensional approach > Prevalence of ADHD
What the sources say
- Disputedcites [11] Caye A, Rocha TB, Anselmi L, Murray J, Menezes AM, Barros FC, et al. Attention-deficit/hyperactivity disorder trajectories from childhood to young adulthood: evidence from a birth cohort supporting a late-onset syndrome. JAMA Psychiatry. 2016;73(7):705–12. sourceExperimental — accuracy not yet measured
The Abstract reports that only 17.2% of children with ADHD continued to have ADHD as young adults, contrary to the claim that children with ADHD do not outgrow the disorder. The discussion adds that the childhood-ADHD group could remain impaired in adult life despite no longer qualifying for an ADHD diagnosis. Page numbers are not provided in our copy. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Disputedcites [12] Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M, et al. Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am J Psychiatry. 2015;172(10):967–77. sourceExperimental — accuracy not yet measured
The Discussion (‘The childhood-ADHD group’) says virtually all former-ADHD children no longer met full diagnostic criteria at age 38. It distinguishes outgrowing the ADHD diagnosis from retaining neuropsychological deficits and life difficulties, so it does not support the claim that children with ADHD do not outgrow the disorder. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Disputedcites [13] Agnew-Blais JC, Polanczyk GV, Danese A, Wertz J, Moffitt TE, Arseneault L. Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood. JAMA Psychiatry. 2016;73(7):713–20. sourceExperimental — accuracy not yet measured
The Discussion section, under “Most children with ADHD will remit by age 18 but impairment remains,” says the majority of children with ADHD no longer met diagnostic criteria at 18. Although those who remitted remained impaired, the paper contradicts the unqualified claim that children with ADHD do not outgrow the disorder. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Many studies have reported improvements in comorbid psychiatric symptoms when ADHD is effectively treated.”
§ Adult ADHD and comorbid disorders: clinical implications of a dimensional approach > Pharmacologic treatments
What the sources say
- Not checked — no full text of the sourcecites [111] Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, et al. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety. 2009;26(3):212–21. source
- Not checked — no full text of the sourcecites [112] Spencer TJ, Faraone SV, Michelson D, Adler LA, Reimherr FW, Glatt SJ, et al. Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity. J Clin Psychiatry. 2006;67(3):415–20. source
- Disputedcites [113] Biederman J, Mick E, Spencer T, Surman C, Faraone SV. Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD. CNS Neurosci Ther. 2012;18(2):126–32. sourceExperimental — accuracy not yet measured
The Discussion (page not specified) says that stimulants do not treat depression or anxiety disorders, rather than reporting improvement in those comorbid conditions when ADHD is treated. The Results (page not specified) found a significant ADHD response to OROS-methylphenidate but no difference from placebo in depression or anxiety symptoms. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [114] Gabriel A. The mixed amphetamine salt extended release (Adderall XR, max-XR) as an adjunctive to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety: an open-label study. Atten Defic Hyperact Disord. 2010;2(2):87–92. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Taken together, such observations suggest the existence of two separate syndromes that have distinct developmental trajectories [11].”
§ Adult ADHD and comorbid disorders: clinical implications of a dimensional approach > Prevalence of ADHD
What the sources say
- Supportedcites [11] Caye A, Rocha TB, Anselmi L, Murray J, Menezes AM, Barros FC, et al. Attention-deficit/hyperactivity disorder trajectories from childhood to young adulthood: evidence from a birth cohort supporting a late-onset syndrome. JAMA Psychiatry. 2016;73(7):705–12. source
The Conclusions and Relevance passage states that the study’s findings suggest the existence of two ADHD syndromes with distinct developmental trajectories. The citing sentence retains that tentative framing by saying the observations ‘suggest’ their existence. (LLM, conf=0.95)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“it is often unrecognized in patients who present to the clinic (reviewed by Ginsberg et al., 2014) [18]”
§ Adult ADHD and comorbid disorders: clinical implications of a dimensional approach > Prevalence of ADHD
What the sources say
- Supportedcites [18] Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014;16(3). source
The review’s Clinical Presentation of Adult Psychiatric Patients With ADHD section describes underrecognition of ADHD and reports previously undiagnosed cases among patients attending a general psychiatric clinic. Its Clinical Points also state that ADHD is underdiagnosed in adults. Page numbers were not provided in the passages. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“corroborating Volkow et al.'s (2012) conclusion that methylphenidate-elicited dopamine increases were associated with therapeutic response in individuals with ADHD [46].”
§ Adult ADHD and comorbid disorders: clinical implications of a dimensional approach > Neurobiological and genetic concepts
What the sources say
- Supportedcites [46] Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, et al. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci. 2012;32(3):841–9. source
The Discussion (page not available) states that methylphenidate-induced dopamine increases were associated with clinical response in a trial of adults with ADHD. It specifies that ventral-striatal increases were associated with improvement in inattention symptoms. (LLM, conf=0.94)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
44 more claims · 9 with their cited sources checked
Create a free account to see all 105 claims and every source verdict.
- Probably not a substantial claim. 30
- It may state two separate claims as one. 42
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“as many as 80% of patients with ADHD have at least 1 coexisting psychiatric disorder [6,17,18].”
From A Digital Mental Health Support Program for Depression and Anxiety in Populations With Attention-Deficit/Hyperactivity Disorder: Feasibility and Usability Study (2023) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“approximately 1 in 2 struggles with anxiety disorders (generalized anxiety disorder [GAD]) [17].”
From A Digital Mental Health Support Program for Depression and Anxiety in Populations With Attention-Deficit/Hyperactivity Disorder: Feasibility and Usability Study (2023) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Quantitative studies demonstrate significantly lower self-esteem and higher divorce rates in this population [14,202].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment options that target symptoms of both ADHD and psychiatric comorbidities may be explored,10,28 taking into account potential drug-drug interactions or adverse effects of medications, as some existing ADHD medications have been associated with mood fluctuations that may exacerbate the severity of symptoms in patients with ADHD and comorbid anxiety or depression.7,10”
From Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/ hyperactivity disorder (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, ADHD in adults can be associated with different challenges than those in children and adolescents, such as higher prevalence of psychiatric comorbidities2,17 and functional impairment,7,18 potentially because of increasing life responsibilities and stressors.6,19”
From Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/ hyperactivity disorder (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 5×
“The National Comorbidity Survey reported that adults with ADHD are three times more likely to develop major depressive disorder (MDD), six times more likely to develop dysthymia, and more than four times more likely to have any mood disorder [37].”
BackgroundInfluentialAnterior Cingulate Conflict Monitoring and Adjustments in Control
Kerns, J. G., Cohen, J. D., MacDonald, A. W., Cho, R. Y., Stenger, V. A., & Carter, C. S. (2004) · Science · doi:10.1126/science.1089910 · Cited by 2,891
FARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267 · cited 1×
“ADHD has an estimated childhood prevalence of 4% to 7% [9] with increasing evidence pointing to its continuation into adulthood for between 15% and 65% of individuals [10].”
BackgroundDrevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 1×
“These circuits integrate higher cognitive functions with visceral information and external environmental conditions to affect mood and emotional states, through reciprocal connections with regions of the cortex that are involved with control of higher cognitive functions as well as regions associated with regulation o…”
BackgroundAttention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation
Shaw, P., Eckstrand, K., Sharp, W., Blumenthal, J., Lerch, J. P., Greenstein, D., Clasen, L., Evans, A., Giedd, J., & Rapoport, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707741104 · Cited by 1,819 · cited 4×
“Neuroanatomical gradations in “cool” processing appear to be related to prefrontal dysfunction involving the dorsolateral prefrontal cortex (dlPFC), and the parietal cortex, insula cortex and anterior cingulate cortex (ACC) are also critically involved in executive function as part of a frontal-parietal executive cont…”
MethodInfluentialPrevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601 · cited 1×
“1) [14], with adults with ADHD presenting with symptoms such as: failing to pay attention to detail,”
BackgroundAttention-deficit hyperactivity disorder
Biederman, J., & Faraone, S. V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66915-2 · Cited by 1,463
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
Architectonic subdivision of the human orbital and medial prefrontal cortex
Öngür, D., Ferry, A. T., & Price, J. L. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10609 · Cited by 944 · cited 10×
“As such, one can imagine this low hedonic tone as a key feature shared by MDD and resulting from a shared dysfunction in monoamine signaling, particularly in the ventral striatum [52].”
BackgroundInfluential
Research works printed but not linked: 3
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: 1994.
- Sternat T, Mohamed M, Furtado M, et al. SSRI treatment response may predict undetected attention deficit hyperactivity disorder in depressed patients. Presented at the Anxiety and Depression Association of America (ADAA) Conference 2016; 2 April 2016 (Abstract S2–10).
- National Collaborating Centre for Mental Health (UK). In: Antisocial personality disorder: Treatment, management and prevention. Leicester (UK): British Psychological Society; 2010. (NICE Clinical Guidelines, No. 77). 7, Interventions for people with antisocial personality disorder and associated symptoms and behaviours. https:// www.ncbi.nlm.nih.gov/books/NBK55350/ . Accessed 2 May 2016.
Cited by
A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)
Luo, Y., Weibman, D., Halperin, J. M., & Li, X. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00042 · Cited by 394
“disorders, often co-occur with ADHD and result in increased difficulties for appropriate diagnoses and treatments (Barkley and Brown, 2008; Rosler et al., 2010; Mao and Findling, 2014; Katzman et al., 2017).”
BackgroundDopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
A literature review and meta-analysis on the effects of ADHD medications on functional outcomes
Boland, H., DiSalvo, M., Fried, R., Woodworth, K. Y., Wilens, T., Faraone, S. V., & Biederman, J. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.01.006 · Cited by 240
Chung, W., Jiang, S.-F., Paksarian, D., Nikolaidis, A., Castellanos, F. X., Merikangas, K. R., & Milham, M. P. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.14344 · Cited by 232
Choi, W.-S., Woo, Y. S., Wang, S.-M., Lim, H. K., & Bahk, W.-M. (2022) · PLOS ONE · doi:10.1371/journal.pone.0277175 · Cited by 221
“Similarly, in adults, as far as we know, the two disorders have been related to several common neuroanatomical regions like the dorsolateral prefrontal cortex or the anterior cingulate cortex, which are critically involved with the executive function control network [10].”
BackgroundInfluential
Metadata
- Authors
- Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J.
- Affiliations
- START Clinic (CA)
- University of Alberta (CA)
- Corresponding author
- Katzman, Martin A.
- Venue
- BMC Psychiatry
- Published
- 2017-08-22
- Volume
- 17
- Issue
- 1
- Pages
- 302-302
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC5567978
- OpenAlex
- W2746340968
- Semantic Scholar
- 12141c6d9565a4e3c28a8f92c8847a70086e4cd6
- Cited by
- 732
- References
- 148
- Citations by year
- 2026: 120 · 2025: 118 · 2024: 111 · 2023: 117 · 2022: 92 · 2021: 60 · 2020: 63 · 2019: 38 · 2018: 11 · 2017: 1
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Purdue Canada
- Shire Canada
- Janssen Canada
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Keywords
- adult ADHD, psychiatric comorbidity, dimensional approach, mood disorders, anxiety disorders, substance use disorders, personality disorders, family transmission, neurobiology of ADHD, diagnosis, treatment prioritization, ADHD prevalence
- MeSH terms
- Adult, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Humans, Male, Mental Health, Psychopathology, Quality of Life, Comorbidity, Prevalence, Substance-Related Disorders, Early Medical Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-27, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-27 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. https://app.cochat.ai/papers/10.1186/s12888-017-1463-3
- The paper
- Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017). Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry. https://doi.org/10.1186/s12888-017-1463-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.